Clinical Trial Update: An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the short-term effects of APOMINE in osteoporosis/low bone mass; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• APOMINE

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoporosis | Phase 1, Phase 2 | Status: TERMINATED